Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soledad Fernandez

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Investigation|November 3, 2015
Histone deacetylase 6 inhibition enhances oncolytic viral replication in gliomaHiroshi Nakashima, Johanna K Kaufmann, Pin-Yi Wang, et al.
Cell Host & Microbe|December 8, 2022
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2Panke Qu, John P Evans, Julia N Faraone, et al.
Cancer Research|June 5, 2013
Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutationsRichard L Price, Jieun Song, Katherine Bingmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Correction: Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma TherapyCarmela Passaro, Quazim Alayo, Isabel DeLaura, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Post-Acute Cardiovascular Outcomes of COVID-19 in Children and Adolescents: An EHR Cohort Study from the RECOVER ProjectBingyu Zhang, Deepika Thacker, Ting Zhou, et al.
Cell Reports|April 27, 2023
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variantsPanke Qu, Julia N Faraone, John P Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2018
Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma TherapyCarmela Passaro, Quazim Alayo, Isabella De Laura, et al.
Nature Communications|April 11, 2025
Cardiovascular post-acute sequelae of SARS-CoV-2 in children and adolescents: cohort study using electronic health recordsBingyu Zhang, Deepika Thacker, Ting Zhou, et al.
The Journal of Clinical Investigation|January 31, 2017
Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinomaLindsey N Kent, Sooin Bae, Shih-Yin Tsai, et al.
Circulation. Population Health and Outcomes|February 20, 2026
Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health SystemsNishant P Shah, Eric D Peterson, Peter Shrader, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Investigation|November 3, 2015
Histone deacetylase 6 inhibition enhances oncolytic viral replication in gliomaHiroshi Nakashima, Johanna K Kaufmann, Pin-Yi Wang, et al.
Cell Host & Microbe|December 8, 2022
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2Panke Qu, John P Evans, Julia N Faraone, et al.
Cancer Research|June 5, 2013
Cytomegalovirus contributes to glioblastoma in the context of tumor suppressor mutationsRichard L Price, Jieun Song, Katherine Bingmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Correction: Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma TherapyCarmela Passaro, Quazim Alayo, Isabel DeLaura, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Post-Acute Cardiovascular Outcomes of COVID-19 in Children and Adolescents: An EHR Cohort Study from the RECOVER ProjectBingyu Zhang, Deepika Thacker, Ting Zhou, et al.
Cell Reports|April 27, 2023
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variantsPanke Qu, Julia N Faraone, John P Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2018
Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma TherapyCarmela Passaro, Quazim Alayo, Isabella De Laura, et al.
Nature Communications|April 11, 2025
Cardiovascular post-acute sequelae of SARS-CoV-2 in children and adolescents: cohort study using electronic health recordsBingyu Zhang, Deepika Thacker, Ting Zhou, et al.
The Journal of Clinical Investigation|January 31, 2017
Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinomaLindsey N Kent, Sooin Bae, Shih-Yin Tsai, et al.
Circulation. Population Health and Outcomes|February 20, 2026
Variation in Lipid Management for Atherosclerotic Cardiovascular Disease Across US Health SystemsNishant P Shah, Eric D Peterson, Peter Shrader, et al.
Pageof 11